Coeliac disease in chronic hepatitis C: a French multicentre prospective study

Aliment Pharmacol Ther. 2007 Nov 1;26(9):1209-16. doi: 10.1111/j.1365-2036.2007.03499.x.

Abstract

Background: A prevalence of 1.2% of coeliac disease (CD) in patients with chronic hepatitis C was recently reported, suggesting a possible epidemiological link between these two diseases. However, other studies have not found this relationship.

Aim: To conduct a French multicentre prospective study to assess the prevalence of CD in hepatitis C virus (HCV)-infected patients.

Methods: Between June 2003 and November 2005, 624 consecutive HCV-positive out-patients were tested for antiendomysial IgA antibodies (AEA), antigliadin IgA and IgG antibodies (AGA). Patients with positive AEA or IgA AGA and positive IgG AGA in a context of a high suspicion of CD were asked to undergo gastroscopy with duodenal biopsies.

Results: Isolated IgA AEA, IgA AGA and IgG AGA were 0.16%, 5.7% and 4.4%, respectively. Gastroscopy was required for 39 patients, 31 were performed (eight refusals), but only 25 duodenal biopsies were performed as six patients had cirrhosis. CD was never detected.

Conclusions: The prevalence of CD in HCV-positive patients was 0% (95% confidence interval: 0-0.59%), but there is a low prevalence of CD in the whole French population.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Antibodies / blood*
  • Celiac Disease / epidemiology
  • Celiac Disease / etiology*
  • Female
  • Frankreich
  • Gliadin / blood*
  • Hepatitis C / complications*
  • Humans
  • Immunoglobulin A / blood*
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Virus Diseases / complications
  • Virus Diseases / drug therapy

Substances

  • Antibodies
  • Immunoglobulin A
  • Immunoglobulin G
  • Gliadin